Edwards Lifesciences Net Cash Flow Investment Acquisitions and Disposals Trend

EW -- USA Stock  

USD 138.06  0.77  0.56%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Net Cash Flow Investment Acquisitions and Disposals of Edwards Lifesciences Corporation with missing and latest data points interpolated. A component of Net Cash Flow from Investing representing the net cash inflow (outflow) associated with the acquisition & disposal of investments
Net Cash Flow Investment Acquisitions and Disposals10 Years Trend
Increasing
Very volatile
 Net Cash Flow Investment Acquisitions and Disposals 
      Timeline 

Regression Statistics

Arithmetic Mean (69,464,912)
Coefficient Of Variation (278.81)
Mean Deviation  149,734,211
Median  10,200,000
Standard Deviation  193,673,252
Range  640,000,000
R Value  0.043784
R Squared  0.001917
Significance  0.89
Slope  2,351,859

Edwards Lifesciences Net Cash Flow Investment Acquisitions and Disposals Over Time

2016-12-31  10,200,000 
2017-12-31  10,200,000 
2018-12-31  69,421,053 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

Edwards Lifesciences Upcoming Company Events
Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 25, 2017
Additionally see analysis of Edwards Lifesciences Correlation with competitors. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.